Zobrazeno 1 - 10
of 94
pro vyhledávání: '"F. B. Wright"'
Autor:
Toni J. F. Michael, Daniel F. B. Wright, Jian S. Chan, Matthew J. Coleshill, Parisa Aslani, Dyfrig A. Hughes, Richard O. Day, Sophie L. Stocker
Publikováno v:
ACR Open Rheumatology, Vol 6, Iss 7, Pp 403-411 (2024)
Objective Self‐monitored point‐of‐care urate‐measuring devices are an underexplored strategy to improve adherence to urate‐lowering therapy and clinical outcomes in gout. This study observed patient‐led urate self‐monitoring practice an
Externí odkaz:
https://doaj.org/article/c952bc534f7843cf99591e3d7b259ea7
Autor:
Lisa Stamp, Nicola Dalbeth, Chris Frampton, Susan Reid, Leanne Te Karu, Daniel F B Wright, Vui Suli Tuitaupe
Publikováno v:
BMJ Open, Vol 14, Iss 8 (2024)
Introduction Gout is one of the most common forms of arthritis worldwide. Gout is particularly prevalent in Aotearoa/New Zealand and is estimated to affect 13.1% of Māori men, 22.9% of Pacific men and 7.4% of New Zealand European men. Effective long
Externí odkaz:
https://doaj.org/article/3cf06f11e09e4eeca65e641bc5adf541
Autor:
Hailemichael Z. Hishe, Sophie L. Stocker, Lisa K. Stamp, Nicola Dalbeth, Tony R. Merriman, Amanda Phipps‐Green, Daniel F. B. Wright
Publikováno v:
Clinical and Translational Science, Vol 16, Iss 3, Pp 422-428 (2023)
Abstract The genetic determinants of the allopurinol dose‐concentration relationship have not been extensively studied. We aimed to clarify what factors, including genetic variation in urate transporters, influence oxypurinol pharmacokinetics (PKs)
Externí odkaz:
https://doaj.org/article/2aebadf1e0614baaab3b5062fe752885
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 12, Iss 3, Pp 285-287 (2023)
Externí odkaz:
https://doaj.org/article/ed431872870c4362ac1b5eae96007f2e
Autor:
Lisa K. Stamp, Peter T. Chapman, Murray Barclay, Anne Horne, Christopher Frampton, Tony R. Merriman, Daniel F. B. Wright, Jill Drake, Nicola Dalbeth
Publikováno v:
Clinical and Translational Science, Vol 13, Iss 1, Pp 110-115 (2020)
The aims of this study were to determine factors that predict serum urate (SU) lowering response to allopurinol and the conversion of allopurinol to oxypurinol, and to determine a minimum therapeutic oxypurinol concentration. Data from 129 participan
Externí odkaz:
https://doaj.org/article/d6847952861c41d2860326047a0c9301
Autor:
Isabelle H S Kuan, Luke C Wilson, Jed C Leishman, Samuel Cosgrove, Robert J Walker, Tracey L Putt, John B W Schollum, Daniel F B Wright
Publikováno v:
PLoS ONE, Vol 16, Iss 2, p e0246247 (2021)
We aimed to develop a metformin dosing strategy to optimise efficacy and safety in patients with reduced kidney function. Metformin data from two studies stratified by kidney function were analysed. The relationship between metformin clearance and ki
Externí odkaz:
https://doaj.org/article/12d0d9a0239743b5a988c18b03bc46ef
Autor:
Hailemichael Z. Hishe, Sophie L. Stocker, Lisa K. Stamp, Nicola Dalbeth, Tony R. Merriman, Amanda Phipps‐Green, Daniel F. B. Wright
Publikováno v:
Clinical and Translational Science. 16:422-428
The genetic determinants of the allopurinol dose-concentration relationship have not been extensively studied. We aimed to clarify what factors, including genetic variation in urate transporters, influence oxypurinol pharmacokinetics (PKs). A populat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8a88b50214efe4667119701db1e8583
https://doi.org/10.1111/cts.13460
https://doi.org/10.1111/cts.13460
Publikováno v:
British Journal of Clinical Pharmacology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e884e687a69cc29cd531ab5b1aeac955
https://doi.org/10.1111/bcp.15722
https://doi.org/10.1111/bcp.15722
Publikováno v:
Pharmacy, Vol 8, Iss 2, p 83 (2020)
(1) Background: The processes and skills required to make decisions about drug therapy have been termed “therapeutic decision-making” in pharmacy practice. The aim of this study was to evaluate a tool constructed to measure the development of the
Externí odkaz:
https://doaj.org/article/5c1273d0404f4920889b2cbd19eb835d
Autor:
Robert R. Bies, Daniel F. B. Wright
Publikováno v:
British Journal of Clinical Pharmacology. 88:1403-1405
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f82f7aa6498a5551448e28ba274b5074
https://doi.org/10.1111/bcp.15289
https://doi.org/10.1111/bcp.15289